Cydectin TriclaMox 1mg/ml + 50 mg/ml Oral Solution for sheep

País: Irlanda

Idioma: inglés

Fuente: HPRA (Health Products Regulatory Authority)

Cómpralo ahora

Ficha técnica Ficha técnica (SPC)
29-05-2023
DSU DSU (DSU)
30-01-2024

Ingredientes activos:

Moxidectin; Triclabendazole

Disponible desde:

Zoetis Belgium S.A.

Código ATC:

QP54AB52

Designación común internacional (DCI):

Moxidectin; Triclabendazole

Dosis:

1/50 milligram(s)/millilitre

formulario farmacéutico:

Oral solution

tipo de receta:

POM: Prescription Only Medicine as defined in relevant national legislation

Grupo terapéutico:

Sheep

Área terapéutica:

moxidectin, combinations

indicaciones terapéuticas:

Endectoparasiticides

Estado de Autorización:

Authorised

Fecha de autorización:

2013-12-09

Ficha técnica

                                ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Cydectin TriclaMox 1 mg/ml + 50 mg/ml oral solution for sheep
Cydectin TriclaMox 1 mg/ml + 50 mg/ml orale Lösung für Schafe
(Austria, Germany)
Cydectine TriclaMox 1 mg/ml + 50 mg/ml solution orale pour ovins
(Belgium, France, Luxembourg)
Cydectin TriclaMox 1 mg/ml + 50 mg/ml Πόσιμο διάλυμα
για πρόβατα (Greece)
Cydectin TriclaMox 1 mg/ml + 50 mg/ml
mixtúra, lausn handa sauðfé (Iceland)
Cydectin TriclaMox 1 mg/ml + 50 mg/ml soluzione orale per pecore
(Italy)
Cydectin TriclaMox 1 mg/ml + 50 mg/ml oral solution for sheep
(Ireland, UK)
Cydectin TriclaMox 1 mg/ml + 50 mg/ml orale oplossing voor schapen
(The Netherlands)
Cydectin TriclaMox 1 mg/ml + 50 mg/ml solução oral para ovinos
(Portugal)
Cydectin TriclaMox 1 mg/ml + 50 mg/ml solución oral para ovino
(Spain)
TriclaMox vet. 1 mg/ml + 50 mg/ml, oral lösning till får (Sweden)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCES:
Moxidectin
1.0 mg
Triclabendazole
50.0 mg
EXCIPIENTS:
QUALITATIVE
COMPOSITION OF EXCIPIENTS AND
OTHER CONSTITUENTS_ _
QUANTITATIVE
COMPOSITION
IF THAT INFORMATION IS
ESSENTIAL
FOR PROPER ADMINISTRATION OF THE
VETERINARY MEDICINAL PRODUC
t
_ _
Benzyl alcohol (E1519)
40.0 mg
Butylhydroxytoluene (E321)
1.0 mg
Polysorbate 80
_ _
Sorbitan oleate
Propylene glycol, dicaprylocaprate
A clear yellow to brown liquid.
3.
CLINICAL INFORMATION
3.1
TARGET SPECIES
Sheep.
3.2
INDICATIONS FOR USE FOR EACH TARGET SPECIES
For the treatment of mixed nematode and fluke infections, caused by
moxidectin and triclabendazole
sensitive strains of:
PARASITE
ADULT STAGE
L4
INHIBITED STAGES
NEMATODES
GASTRO-INTESTINAL NEMATODES:
_Haemonchus contortus_
•
•
•
_Teladorsagia circumcincta_
•
•
•
_Ostertagia trifurcata_
•
•
_Trichostrongylus axei_
•
•
•
_Trichostrongylus colubriformis_
•
•
_Trichostrongylus vitrinus_
•
•
_Nematodirus battus_
•
•
_Nematodirus spathiger_
•
•
_Nematodirus filicolis_

                                
                                Leer el documento completo
                                
                            

Buscar alertas relacionadas con este producto